Effect of CBD on sleep quality in MS
The CanISleepinMS Study: Effect of cannabidiol (CBD) on sleep quality in patients with multiple sclerosis, a series of 15 randomised, placebo controlled N-of-1 trials
What was tested
Treatment tested
- Cannabidiol
Cannabinoid CB1 receptor negative allosteric modulator
What it measured
Main measures
Primary endpoint: Insomnia Severity Index (ISI)
Mood and sleep
Other measures (1)
Secondary endpoints: diary measurements (sleep-related outcomes:
Mood and sleep
Loading reviews and guidelines…
Related trials
- BLCL-THC/CBD-01
Phase 2 · Recruiting
Still running
- CanISleepinMS
Phase 2 · Completed
No result found
- Botulinum Toxin in Patients With Spastic Lower Limb Pares…
Phase 3 · Completed
No result found
- " Treating MS Patients With Lower Extremity Spasticity Us…
Phase 3 · Status unknown
No result found
- OS440-3005
Phase 3 · Completed
Results posted, no main test reported
- SARR
Not a drug-phase study · Completed
Result in a paper, not read yet
History
- In scope changed from true to false
Started
Sept 2024
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error